AGENTUS
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Sept 2022)
What this means for you
This application is over — abandoned 12 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90608923
- Mark type
- Stylized text
- Filed
- 29 Mar 2021
- Published for opposition
- 14 Dec 2021
- Abandoned
- 12 Sept 2022
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease
- Class 042 — Scientific and technological services: Pharmaceutical, medical, scientific, and biopharmaceutical research and development
Owner
- Agenus Inc., Lexington, MA, US
- Agenus Inc., Lexington, MA, US
Prosecution history
- 12 Sept 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Sept 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Feb 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Dec 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Dec 2021 — PUBLISHED FOR OPPOSITION
- 24 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Nov 2021 — ASSIGNED TO EXAMINER
- 04 Jul 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Apr 2021 — NEW APPLICATION ENTERED